Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4646143
Max Phase: Preclinical
Molecular Formula: C78H114N20O19S
Molecular Weight: 1667.96
Molecule Type: Unknown
Associated Items:
ID: ALA4646143
Max Phase: Preclinical
Molecular Formula: C78H114N20O19S
Molecular Weight: 1667.96
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC[C@H](C)[C@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(N)=O
Standard InChI: InChI=1S/C78H114N20O19S/c1-9-42(6)65(78(117)97-53(32-45-22-14-11-15-23-45)73(112)93-55(34-59(80)99)67(106)86-39-62(83)102)98-69(108)50(27-29-118-8)89-74(113)54(33-46-38-85-48-25-17-16-24-47(46)48)92-68(107)49(26-18-19-28-79)88-72(111)52(31-44-20-12-10-13-21-44)91-71(110)51(30-40(2)3)90-66(105)43(7)87-70(109)56(35-60(81)100)94-76(115)58(37-63(103)104)95-75(114)57(36-61(82)101)96-77(116)64(84)41(4)5/h10-17,20-25,38,40-43,49-58,64-65,85H,9,18-19,26-37,39,79,84H2,1-8H3,(H2,80,99)(H2,81,100)(H2,82,101)(H2,83,102)(H,86,106)(H,87,109)(H,88,111)(H,89,113)(H,90,105)(H,91,110)(H,92,107)(H,93,112)(H,94,115)(H,95,114)(H,96,116)(H,97,117)(H,98,108)(H,103,104)/t42-,43-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,64-,65-/m0/s1
Standard InChI Key: KUOOBJGADNFYNT-GGTFGJAXSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1667.96 | Molecular Weight (Monoisotopic): 1666.8290 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Saitoh M, Takayama K, Hitachi K, Taguchi A, Taniguchi A, Tsuchida K, Hayashi Y.. (2020) Discovery of a follistatin-derived myostatin inhibitory peptide., 30 (3): [PMID:31874826] [10.1016/j.bmcl.2019.126892] |
Source(1):